No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 8,580 | 9,814 | 11,720 | 10,460 | 10,339 | 9,656 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 560 | 1,286 | 1,526 | 388 | 436 | 480 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
UPM-Kymmene Oyj, established in 1871 and headquartered in Helsinki, Finland, is a global player in the forest-based bioindustry. The company organizes its diverse operations across several key segments, including UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and other business areas. UPM is a significant producer of wood-derived materials, supplying softwood, birch, and eucalyptus pulp used in the creation of tissue, specialty, graphic papers, and packaging. It also provides sawn timber for various applications in joinery, packaging, furniture, planning, and construction. Beyond traditional timber products, the company innovates in sustainable fuels, producing wood-based renewable diesel and naphtha for the petrochemical sector, and generates electricity from its hydro and nuclear power plants. In the realm of paper and labeling, UPM offers self-adhesive label materials crucial for branding, promotion, and functional labeling across diverse industries such as food, beverage, personal care, pharmaceuticals, and logistics. Its product range also includes label papers, release base papers, office papers, and flexible packaging for printing, packing, and commercial siliconizing, alongside graphic papers tailored for advertising, publishing, and home/office use. Furthermore, UPM is a leading supplier of plywood and veneer products, which are vital for construction, vehicle flooring, liquefied natural gas (LNG) shipbuilding, parquet manufacturing, and various other industrial applications. The company also extends its expertise through forestry services, providing wood and biomass to forest investors and owners. Its innovative offerings encompass wood-based lignin for industrial applications, cell hydrogels for 3D cell culturing, UPM ProFi decking products, UPM formi granules, and a range of biomedical products. UPM maintains an expansive international presence, conducting operations across Europe, North America, Asia, and other global markets.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
UPM-Kymmene Oyj, established in 1871 and headquartered in Helsinki, Finland, is a global player in the forest-based bioindustry. The company organizes its diverse operations across several key segments, including UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and other business areas. UPM is a significant producer of wood-derived materials, supplying softwood, birch, and eucalyptus pulp used in the creation of tissue, specialty, graphic papers, and packaging. It also provides sawn timber for various applications in joinery, packaging, furniture, planning, and construction. Beyond traditional timber products, the company innovates in sustainable fuels, producing wood-based renewable diesel and naphtha for the petrochemical sector, and generates electricity from its hydro and nuclear power plants. In the realm of paper and labeling, UPM offers self-adhesive label materials crucial for branding, promotion, and functional labeling across diverse industries such as food, beverage, personal care, pharmaceuticals, and logistics. Its product range also includes label papers, release base papers, office papers, and flexible packaging for printing, packing, and commercial siliconizing, alongside graphic papers tailored for advertising, publishing, and home/office use. Furthermore, UPM is a leading supplier of plywood and veneer products, which are vital for construction, vehicle flooring, liquefied natural gas (LNG) shipbuilding, parquet manufacturing, and various other industrial applications. The company also extends its expertise through forestry services, providing wood and biomass to forest investors and owners. Its innovative offerings encompass wood-based lignin for industrial applications, cell hydrogels for 3D cell culturing, UPM ProFi decking products, UPM formi granules, and a range of biomedical products. UPM maintains an expansive international presence, conducting operations across Europe, North America, Asia, and other global markets.
